ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration

Wang, Zhengguang; Cao, Lei; Zhou, Sitong; Lyu, Jin; Gao, Yang*; Yang, Ronghua*佛山市第一人民医院; 南开大学; 中国医科大学; 1; y
Frontiers in Immunology2022-3-22DOI: 10.3389/fimmu.2022.854785
23被引7阅读
引用收藏
分享

摘要

Increasing evidence has demonstrated that pyroptosis, a type of inflammatory programmed cell death, plays an important role in the pathogenesis and progression of gastric cancer. However, it remains unclear whether pyroptosis-related long non-coding RNAs (lncRNAs) can be used to predict the diagnosis and prognosis of gastric adenocarcinoma. This study aimed to evaluate and test the role of the lncRNA signature associated with pyroptosis as a prognostic tool for stomach adenocarcinoma (STAD) and to ascertain their immune value. Relative RNA-sequencing data were extracted from The Cancer Genome Atlas database (TCGA), and data preprocessing was performed for STAD. Pearson correlation analysis was used to determine whether lncRNAs were significantly correlated with pyroptosis based on 23 genes related to pyroptosis. Univariate Cox regression and least absolute shrinkage and selection operator(LASSO) analyses were both adopted to select features and establish the pyroptosis-related lncRNA (PRL) prognostic signature. Kaplan-Meier(KM) survival analysis of the different risk groups was conducted according to the risk scores. We further examined the functional enrichment, tumor microenvironment, and landscape of mutation status among the different risk groups, and these analyses further explained the reasons for the differences in the prediction as well as survival value of the different risk groups. Four lncRNAs, including HAND2-AS1, LINC01354, RP11-276H19.1, and PGM5-AS1, were involved in the PRL signature and used to split STAD patients into two risk groups. Overall survival time(OS) was significantly higher in the low-risk group than in the high-risk group in both the training and validation groups. Functional enrichment analysis was further employed to analyze differentially expressed genes in high- and low-risk groups to identify potential molecular functions and pathways associated with pyroptosis in the gastric cancer microenvironment. Protein-protein interaction (PPI) and Friends analysis identified hub genes that may play a key role in differentially expressed genes in high- and low-risk groups. In addition, there were remarkable discrepancies between the different risk groups in the tumor stage (P < 0.01) and histologic grade (P < 0.05). Furthermore, drug-susceptibility testing indicated potential sensitive chemotherapeutic drugs for each risk group. This study is the first to establish and validate STAD-associated PRLs that can effectively guide the prognosis and the immune microenvironment in STAD patients and provide evidence for the development of molecularly targeted therapies related to pyroptosis.

学科与关键词

关键词
stomach adenocarcinomaprognostic signaturetumor microenvironmentpyroptosisimmune infiltration
相关
加载中…
  • Constructing and Validating a Pyroptosis-Related Genes Prognostic Signature for Stomach Adenocarcinoma and Immune Infiltration: Potential Biomarkers for Predicting the Overall Survival
    Xu, Jingmin; Chen, Ke; Wei, Zhou; Wu, Zixuan; Huang, Xuyan; Cai, Minjie; Yuan, Kai; Huang, Peidong; Zhang, Jing; Wang, Shuai*Journal of Oncology, 2022, 2022: 3102743.
  • A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma
    Zhao, Kai; Li, Xiangyu; Shi, Yuanxin; Lu, Yun; Qiu, Peng; Deng, Zhengdong; Yao, Wei*; Wang, Jianming*Frontiers in Genetics, 2022, 13: 899496.被引 11
  • Comprehensive Analysis of an Individualized Immune-Related lncRNA Pair Signature in Gastric Cancer
    Nie, Chuang; Zhai, Jiabao; Wang, Qi; Zhu, Xiaojie; Xiang, Guanghui; Liu, Chang; Liu, Tianyu; Wang, Wanyu; Wang, Yimin; Zhao, Yashuang; Tian, Wenjing*; Xue, Yingwei*; Zhou, Haibo*Frontiers in Cell and Developmental Biology, 2022, 10: 805623.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-03-22
卷期
第 13 卷
页码
854785
DOI
10.3389/fimmu.2022.854785
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • W

    Wang, Zhengguang (第一作者)

    1 · china med univ

  • C

    Cao, Lei

    tianjin union med ctr

查看全部 6 位作者收起作者
  • Z

    Zhou, Sitong

    first peoples hosp foshan

  • L

    Lyu, Jin

    first peoples hosp foshan

  • G

    Gao, Yang (通讯)

    nankai univ

  • Y

    Yang, Ronghua (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417